Promoter Methylation of <i>PRKCB</i>, <i>ADAMTS12</i>, and <i>NAALAD2</i> Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence

Promoter Methylation of <i>PRKCB</i>, <i>ADAMTS12</i>, and <i>NAALAD2</i> Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence

The molecular diversity of prostate cancer (PCa) has been demonstrated by recent genome-wide studies, proposing a significant number of different molecular markers. However, only a few of them have been transferred into clinical practice so far. The present study aimed to identify and validate novel...

Full description

Bibliographic Details
Main Authors: Kristina Daniunaite, Arnas Bakavicius, Kristina Zukauskaite, Ieva Rauluseviciute, Juozas Rimantas Lazutka, Albertas Ulys, Feliksas Jankevicius, Sonata Jarmalaite
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:International Journal of Molecular Sciences
Subjects:
prostate cancer
biochemical recurrence
DNA methylation
<i>ADAMTS12</i>
<i>NAALAD2</i>
<i>PRKCB</i>
Online Access:https://www.mdpi.com/1422-0067/22/11/6091

Internet

https://www.mdpi.com/1422-0067/22/11/6091

Similar Items